Personalis Inc. (PSNL)
NASDAQ
Real-time Data
01:30 PM
Day's Range
12.3152 wk Range
3.84Overview - PSNL - Personalis Inc.
Key Statistics
Valuation
Enterprise Value
1.66B
P/E (Trailing)
‪-18.67‬
P/E (Forward)
‪-18.32‬
PEG Ratio
‪-0.61‬
Price / Sales (TTM)
‪26.44‬
Price / Book
‪7.80‬
EV / EBITDA
‪-15.94‬
Profitability
Gross Margin
‪21.21%‬
Profit Margin
‪-153.83%‬
Operating Margin
‪-150.24%‬
Return on Assets
‪-25.03%‬
Return on Equity
‪-50.32%‬
Ownership
Shares Outstanding
106.36M
Float
72.33M
Short % of Shares Outstanding
‪12.28%‬
Held by Insiders
‪26.14%‬
Held by Institutions
‪66.73%‬
Price stats
Beta
‪2.28‬
50-Day Avg
‪13.35‬
200-Day Avg
‪9.47‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - PSNL - Personalis Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- PSNLNASDAQPersonalis Inc.1.35BMarket Cap+57.42%52-week change-13.91P/E (Trailing)‪-148.10%‬Profit Margin
- NTRANASDAQNATERA INC (Common Stock) – ticker 45E47.23BMarket Cap+50.52%52-week change-220.14P/E (Trailing)‪-7.10%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.43.33BMarket Cap-16.52%52-week change38.86P/E (Trailing)‪25.03%‬Profit Margin
- ILMNNASDAQIllumina, Inc.33.97BMarket Cap+55.94%52-week change41.66P/E (Trailing)‪18.33%‬Profit Margin
- GHNASDAQGuardant Health Inc.22.13BMarket Cap+61.54%52-week change-49.67P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings Inc.17.13BMarket Cap+23.58%52-week change36.41P/E (Trailing)‪17.66%‬Profit Margin
- ICICLRNASDAQICON plc13.03BMarket Cap-2.92%52-week change272.44P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - PSNL - Personalis Inc.
About
Personalis Inc. is a biotechnology company specializing in advanced genomics services for precision medicine and oncology. Its primary function is to analyze complex genetic information for clinical and academic research, aiding in the development of targeted therapeutics and personalized treatments. The company's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
